Nutrient supplements and cardiovascular disease: A heartbreaking story

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Lichtenstein, Alice H ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Carotenoids; CVD; Folic acid; Vitamin B12; Vitamin B6; Vitamin D; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FOLIC ACID; VITAMIN D;

CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; HEALTH; HUMAN; REVIEW;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FOLIC ACID; HEALTH; HUMANS; VITAMIN D; VITAMIN E;

EID: 66349089274     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800027-JLR200     Document Type: Review

References (69)

1. Voutilainen, S., T. Nurmi, J. Mursu, and T. H. Rissanen. 2006. Carotenoids and cardiovascular health. Am. J. Clin. Nutr. 83: 1265-1271. (Pubitemid 44713054)
2. Di Mascio, P., S. Kaiser, and H. Sies. 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 274: 532-538. (Pubitemid 19261144)
3. Bjelakovic, G., D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 297: 842-857. (Pubitemid 46333949)
4. ATBC study group. 1994. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann. Epidemiol. 4: 1-10.
5. Tornwall, M. E., J. Virtamo, P. A. Korhonen, M. J. Virtanen, P. R. Taylor, D. Albanes, and J. K. Huttunen. 2004. Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur. Heart J. 25: 1171-1178. (Pubitemid 38834075)
6. Omenn, G. S., G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H.Williams, et al. 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334: 1150-1155. (Pubitemid 26137973)
7. Hennekens, C. H., J. E. Buring, J. E. Manson, M. Stampfer, B. Rosner, N. R. Cook, C. Belanger, F. LaMotte, J. M. Gaziano, P. M. Ridker, et al. 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334: 1145-1149. (Pubitemid 26137972)
8. Greenberg, E. R., J. A. Baron, M. R. Karagas, T. A. Stukel, D. W. Nierenberg, M. M. Stevens, J. S. Mandel, and R. W. Haile. 1996. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA. 275: 699-703. (Pubitemid 26073278)
9. McCully, K. S. 1969. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56: 111-128.
10. Harker, L. A., S. J. Slichter, C. R. Scott, and R. Ross. 1974. Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 291: 537-543.
11. Harker, L. A., R. Ross, S. J. Slichter, and C. R. Scott. 1976. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58: 731-741.
12. De Bree, A., W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom. 2002. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol. Rev. 54: 599-618. (Pubitemid 35351198)
13. Stampfer, M. J., M. R. Malinow, W. C. Willett, L. M. Newcomer, B. Upson, D. Ullmann, P. V. Tishler, and C. H. Hennekens. 1992. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268: 877-881.
14. Verhoef, P., C. H. Hennekens, M. R. Malinow, F. J. Kok, W. C. Willett, and M. J. Stampfer. 1994. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 25: 1924-1930. (Pubitemid 24291274)
15. Alfthan, G., J. Pekkanen, M. Jauhiainen, J. Pitkaniemi, M. Karvonen, J. Tuomilehto, J. T. Salonen, and C. Ehnholm. 1994. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106: 9-19. (Pubitemid 24103795)
16. Wierzbicki, A. S. 2007. Homocysteine and cardiovascular disease: a review of the evidence. Diab. Vasc. Dis. Res. 4: 143-150.
17. Lentz, S. R. 2005. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 3: 1646-1654. (Pubitemid 41716550)
18. Bleys, J., E. R. Miller 3rd, R. Pastor-Barriuso, L. J. Appel, and E. Guallar. 2006. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 84: 880-887 (quiz 954-5).
19. Davey Smith, G., and S. Ebrahim. 2005. Folate supplementation and cardiovascular disease. Lancet. 366: 1679-1681. (Pubitemid 41587438)
20. Toole, J. F., M. R. Malinow, L. E. Chambless, J. D. Spence, L. C. Pettigrew, V. J. Howard, E. G. Sides, C. H. Wang, and M. Stampfer. 2004. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 291: 565-575. (Pubitemid 38500310)
21. Lange, H., H. Suryapranata, G. De Luca, C. Borner, J. Dille, K. Kallmayer, M. N. Pasalary, E. Scherer, and J. H. Dambrink. 2004. Folate therapy and in-stent restenosis after coronary stenting. N. Engl. J. Med. 350: 2673-2681. (Pubitemid 38788002)
22. Schnyder, G., M. Roffi, Y. Flammer, R. Pin, and O. M. Hess. 2002. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA. 288: 973-979. (Pubitemid 34920462)
23. Wrone, E. M., J. M. Hornberger, J. L. Zehnder, L. M. McCann, N. S. Coplon, and S. P. Fortmann. 2004. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J. Am. Soc. Nephrol. 15: 420-426. (Pubitemid 38140783)
24. Zoungas, S., B. P. McGrath, P. Branley, P. G. Kerr, C. Muske, R. Wolfe, R. C. Atkins, K. Nicholls, M. Fraenkel, B. G. Hutchison, et al. 2006. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J. Am. Coll. Cardiol. 47: 1108-1116.
25. Jamison, R. L., P. Hartigan, J. S. Kaufman, D. S. Goldfarb, S. R. Warren, P. D. Guarino, J. M. Gaziano, and I. Veterans Affairs Site. 2007. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 298: 1163-1170. (Pubitemid 47403102)
26. Liem, A. H., A. J. van Boven, N. J. Veeger, A. J. Withagen, R. M. Robles de Medina, J. G. Tijssen, D. J. van Veldhuisen and the Folic Acid on Risk Diminishment After Acute Myocarial Infarction Study Group. 2004. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int. J. Cardiol. 93: 175-179. (Pubitemid 38229585)
27. Potena, L., F. Grigioni, G. Magnani, P. Ortolani, F. Coccolo, S. Sassi, K. Koessels, C. Marrozzini, A. Marzocchi, S. Carigi, et al. 2005. Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. Am. J. Transplant. 5: 2258-2264. (Pubitemid 41655776)
28. Bonaa, K. H., I. Njolstad, P. M. Ueland, H. Schirmer, A. Tverdal, T. Steigen, H. Wang, J. E. Nordrehaug, E. Arnesen, K. Rasmussen, et al. 2006. Homocysteine lowering and cardiovascular events after acute myocardial infarction. [see comment] N. Engl. J. Med. 354: 1578-1588.
29. Lonn, E., S. Yusuf, M. J. Arnold, P. Sheridan, J. Pogue, M. Micks, M. J. McQueen, J. Probstfield, G. Fodor, C. Held, et al. 2006. Homo- cysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354: 1567-1577.
30. Albert, C. M., N. R. Cook, J. M. Gaziano, E. Zaharris, J. MacFadyen, E. Danielson, J. E. Buring, and J. E. Manson. 2008. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 299: 2027-2036. (Pubitemid 351656584)
31. Ebbing, M., O. Bleie, P. M. Ueland, J. E. Nordrehaug, D. W. Nilsen, S. E. Vollset, H. Refsum, E. K. R. Pedersen, and O. Nygard. 2008. Mortality and cardiovascular events in patients treated with homocysteine- lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 300: 795-804.
32. Michos, E. D., and M. L. Melamed. 2008. Vitamin D and cardiovascular disease risk. Curr. Opin. Clin. Nutr. Metab. Care. 11: 7-12. (Pubitemid 350295219)
33. Michos, E. D., and R. S. Blumenthal. 2007. Vitamin D supplementation and cardiovascular disease risk. Circulation. 115: 827-828. (Pubitemid 46294722)
34. Zittermann, A., S. S. Schleithoff, and R. Koerfer. 2005. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94: 483-492. (Pubitemid 41555486)
35. Rajasree, S., K. Rajpal, C. C. Kartha, P. S. Sarma, V. R. Kutty, C. S. Iyer, and G. Girija. 2001. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. [see comment] Eur. J. Epidemiol. 17: 567-571. (Pubitemid 34252685)
36. Lund, B., J. Badskjaer, B. Lund, and O. H. Soerensen. 1978. Vitamin D and ischaemic heart disease. Horm. Metab. Res. 10: 553-556. (Pubitemid 9080109)
37. Vik, B., K. Try, D. S. Thelle, and O. H. Forde. 1979. Tromso Heart Study: vitamin D metabolism and myocardial infarction. BMJ. 2: 176. (Pubitemid 9219912)
38. Melamed, M. L., P. Muntner, E. D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi. 2008. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28: 1179-1185.
39. Giovannucci, E., Y. Liu, B. W. Hollis, and E. B. Rimm. 2008. 25- hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168: 1174-1180. (Pubitemid 351831400)
40. Wang, T. J., M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan. 2008. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 117: 503-511.
41. Dobnig, H., S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, B. Wellnitz, J. Kinkeldei, B. O. Boehm, G. Weihrauch, and W. Maerz. 2008. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168: 1340-1349. (Pubitemid 351930842)
42. Hsia, J., G. Heiss, H. Ren, M. Allison, N. C. Dolan, P. Greenland, S. R. Heckbert, K. C. Johnson, J. E. Manson, S. Sidney, et al. 2007. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 115: 846-854. (Pubitemid 46294725)
43. IOM. 1997. Dietary Reference Intakes. Calcium, phosphorus, magnesium, vitamin D and fluoride, National Academy of Sciences, Washington, D.C.
44. Jurgens, G., H. F. Hoff, G. M. Chisolm 3rd, and H. Esterbauer. 1987. Modification of human serum low density lipoprotein by oxidation- characterization and pathophysiological implications. Chem. Phys. Lipids. 45: 315-336. (Pubitemid 17152339)
45. Esterbauer, H., G. Striegl, H. Puhl, S. Oberreither, M. Rotheneder, M. el-Saadani, and G. Jurgens. 1989. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann. N. Y. Acad. Sci. 570: 254-267. (Pubitemid 20103401)
46. Reaven, P. D., A. Khouw, W. F. Beltz, S. Parthasarathy, and J. L. Witztum. 1993. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler. Thromb. 13: 590-600. (Pubitemid 23107133)
47. Jialal, I., and S. M. Grundy. 1992. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J. Lipid Res. 33: 899-906.
48. Bocan, T. M., S. B. Mueller, E. Q. Brown, P. D. Uhlendorf, M. J. Mazur, and R. S. Newton. 1992. Antiatherosclerotic effects of anti-oxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits. Exp. Mol. Pathol. 57: 70-83.
49. Verlangieri, A. J., and M. J. Bush. 1992. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11: 131-138.
50. Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328: 1450-1456. (Pubitemid 23143847)
51. Stampfer, M. J., C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328: 1444-1449. (Pubitemid 23143846)
52. Knekt, P., A. Reunanen, R. Jarvinen, R. Seppanen, M. Heliovaara, and A. Aromaa. 1994. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139: 1180-1189. (Pubitemid 24184411)
53. Kushi, L. H., A. R. Folsom, R. J. Prineas, P. J. Mink, Y. Wu, and R. M. Bostick. 1996. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. [see comment] N. Engl. J. Med. 334: 1156-1162. (Pubitemid 26137974)
54. Wright, M. E., K. A. Lawson, S. J. Weinstein, P. Pietinen, P. R. Taylor, J. Virtamo, and D. Albanes. 2006. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. [see comment] Am. J. Clin. Nutr. 84: 1200-1207. (Pubitemid 44730393)
55. Boaz, M., S. Smetana, T. Weinstein, Z. Matas, U. Gafter, A. Iaina, A. Knecht, Y. Weissgarten, D. Brunner, M. Fainaru, et al. 2000. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 356: 1213-1218.
56. Stephens, N. G., A. Parsons, P. M. Schofield, F. Kelly, K. Cheeseman, and M. J. Mitchinson. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347: 781-786. (Pubitemid 26091640)
57. Vivekananthan, D. P., M. S. Penn, S. K. Sapp, A. Hsu, and E. J. Topol. 2003. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. [erratum appears in Lancet. 2004 Feb 21;363(9409):662] Lancet. 361: 2017-2023. (Pubitemid 36695043)
58. Ridker, P. M., N. R. Cook, I. M. Lee, D. Gordon, J. M. Gaziano, J. E. Manson, C. H. Hennekens, and J. E. Buring. 2005. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med. 352: 1293-1304.
59. Sesso, H. D., J. E. Buring, W. G. Christen, T. Kurth, C. Belanger, J. MacFadyen, V. Bubes, J. E. Manson, R. J. Glynn, and J. M. Gaziano. 2008. Vitamins E and C in the Prevention of Cardiovascular Disease in Men. JAMA. 300: 2123-2133.
60. Miller 3rd, E. R., R. Pastor-Barriuso, D. Dalal, R. A. Riemersma, L. J. Appel, and E. Guallar. 2005. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142: 37-46.
61. IOM. 2000. Dietary Reference Intakes. Vitamin C, vitamin E, selenium and carotenoids, National Academy of Sciences, Washington, D.C.
62. IOM. 1998. Dietary Reference Intakes. Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline, National Academy of Sciences, Washington, D.C.
63. Moats, C., and E. B. Rimm. 2007. Vitamin intake and risk of coronary disease: observation versus intervention. Curr. Atheroscler. Rep. 9: 508-514.
64. Slesinski, M. J., A. F. Subar, and L. L. Kahle. 1995. Trends in use of vitamin and mineral supplements in the United State: the 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc. 95: 921-923.
65. Levy, A. S., and R. E. Schucker. 1987. Patterns of nutrient intake among dietary supplement users: attitudinal and behavioral correlates. J. Am. Diet. Assoc. 87: 754-760. (Pubitemid 17088963)
66. Pelletier, D. L., and A. Kendall. 1997. Supplement use may not be associated with better food intake in all population groups. Family Economics and Nutrition Review. 10: 32-44.
67. Murphy, S. P., K. K. White, S. Y. Park, and S. Sharma. 2007. Multivitamin-multimineral supplements' effect on total nutrient intake. Am. J. Clin. Nutr. 85: 280S-284S. (Pubitemid 46067649)
68. Rock, C. L. 2007. Multivitamin-multimineral supplements: who uses them? Am. J. Clin. Nutr. 85: 277S-279S. (Pubitemid 46067648)
69. Dickersin, K., and D. Rennie. 2003. Registering clinical trials. JAMA. 290: 516-523. (Pubitemid 37448502)